Administration of Obinutuzumab, and Not Rituximab, during Induction and Maintenance for Follicular Lymphoma Increases the Likelihood of Developing Delayed NeutropeniaShimrit Harlev, Nashwa Fadaos,Tehila Azoulay,Ronit Leiba,Nurit Horesh,Tsofia Inbar,Netanel A. Horowitz, Inna Tsoran-Rosenthal,Noa Lavi,Eldad J. Dann,Tsila ZuckermanBlood(2022)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要